Table 2 Baseline demographics
Demographics | Favipiravir | Placebo | Total | |
|---|---|---|---|---|
Gender, N (%) | Male | 17 (73.91 %) | 14 (66.67 %) | 31 (70.45 %) |
Female | 6 (26.09 %) | 7 (33.33 %) | 13 (29.55 %) | |
Total | 23 (100 %) | 21 (100 %) | 44 (100 %) | |
Not available | 0 | 0 | 0 | |
Race, N (%) | Caucasian | 12 (52.17 %) | 14 (66.67 %) | 26 (59.09 %) |
African | 0 (0 %) | 1 (4.76 %) | 1 (2.27 %) | |
Asian | 3 (13.04 %) | 3 (14.29 %) | 6 (13.64 %) | |
Other | 8 (34.78 %) | 3 (14.29 %) | 11 (25 %) | |
Total | 23 (99.99 %) | 21 (100.01 %) | 44 (100 %) | |
Not available | 0 | 0 | 0 | |
Age | N | 23 | 21 | 44 |
Mean (SD) | 51.43 (11.43) | 50.86 (9.92) | 51.16 (10.61) | |
Median (P25, P75) | 51 (42.5, 60.5) | 52 (45, 59) | 51.5 (44.25, 59.75) | |
Min, max | (33, 70) | (32, 64) | (32, 70) | |
Not available | 0 | 0 | 0 | |
Height | N | 23 | 21 | 44 |
Mean (SD) | 167.87 (10.85) | 165.57 (9.12) | 166.77 (10.01) | |
Median (P25, P75) | 168 (162, 172) | 166 (163, 172) | 167 (162, 172.5) | |
Min, max | (146, 193) | (146, 179) | (146, 193) | |
Not available | 0 | 0 | 0 | |
Weight | N | 23 | 21 | 44 |
Mean (SD) | 79.94 (15.5) | 77.94 (9.45) | 78.99 (12.86) | |
Median (P25, P75) | 80 (72.75, 86.5) | 75.8 (71.2, 81.8) | 77.4 (71.42, 85) | |
Min, max | (51, 120) | (64, 98) | (51, 120) | |
Not available | 0 | 0 | 0 | |